| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| CD274 | CD4 | ENSCJAP00000020977 | ENSCJAP00000043597 | Uncharacterized protein. | Ig-like domain-containing protein. | 0.771 |
| CD274 | CD80 | ENSCJAP00000020977 | ENSCJAP00000078516 | Uncharacterized protein. | Uncharacterized protein. | 0.964 |
| CD274 | CTLA4 | ENSCJAP00000020977 | ENSCJAP00000064098 | Uncharacterized protein. | Cytotoxic T-lymphocyte associated protein 4. | 0.685 |
| CD274 | IDO1 | ENSCJAP00000020977 | ENSCJAP00000011933 | Uncharacterized protein. | Indoleamine 2,3-dioxygenase 1. | 0.633 |
| CD274 | IFNG | ENSCJAP00000020977 | ENSCJAP00000056963 | Uncharacterized protein. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | 0.694 |
| CD274 | JAK1 | ENSCJAP00000020977 | ENSCJAP00000030953 | Uncharacterized protein. | Tyrosine-protein kinase. | 0.727 |
| CD274 | LAG3 | ENSCJAP00000020977 | ENSCJAP00000014207 | Uncharacterized protein. | Lymphocyte activating 3. | 0.639 |
| CD274 | PDCD1 | ENSCJAP00000020977 | ENSCJAP00000036805 | Uncharacterized protein. | Programmed cell death 1. | 0.996 |
| CD274 | SPOPL | ENSCJAP00000020977 | ENSCJAP00000056249 | Uncharacterized protein. | Speckle type BTB/POZ protein like. | 0.605 |
| CD274 | STAT3 | ENSCJAP00000020977 | ENSCJAP00000000719 | Uncharacterized protein. | Signal transducer and activator of transcription. | 0.609 |
| CD4 | CD274 | ENSCJAP00000043597 | ENSCJAP00000020977 | Ig-like domain-containing protein. | Uncharacterized protein. | 0.771 |
| CD4 | CD80 | ENSCJAP00000043597 | ENSCJAP00000078516 | Ig-like domain-containing protein. | Uncharacterized protein. | 0.923 |
| CD4 | CTLA4 | ENSCJAP00000043597 | ENSCJAP00000064098 | Ig-like domain-containing protein. | Cytotoxic T-lymphocyte associated protein 4. | 0.935 |
| CD4 | IDO1 | ENSCJAP00000043597 | ENSCJAP00000011933 | Ig-like domain-containing protein. | Indoleamine 2,3-dioxygenase 1. | 0.787 |
| CD4 | IFNG | ENSCJAP00000043597 | ENSCJAP00000056963 | Ig-like domain-containing protein. | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons; Belongs to the type II (or gamma) interferon family. | 0.966 |
| CD4 | JAK1 | ENSCJAP00000043597 | ENSCJAP00000030953 | Ig-like domain-containing protein. | Tyrosine-protein kinase. | 0.664 |
| CD4 | LAG3 | ENSCJAP00000043597 | ENSCJAP00000014207 | Ig-like domain-containing protein. | Lymphocyte activating 3. | 0.874 |
| CD4 | PDCD1 | ENSCJAP00000043597 | ENSCJAP00000036805 | Ig-like domain-containing protein. | Programmed cell death 1. | 0.909 |
| CD4 | STAT3 | ENSCJAP00000043597 | ENSCJAP00000000719 | Ig-like domain-containing protein. | Signal transducer and activator of transcription. | 0.840 |
| CD80 | CD274 | ENSCJAP00000078516 | ENSCJAP00000020977 | Uncharacterized protein. | Uncharacterized protein. | 0.964 |
